You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen
Published Date: 04 Jul 2025
Cancer Type:
Gynecologic, 
Ovary
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Monitoring section

Updated
Jul 2025
Drug

Published Date: 02 Jul 2025

Revision Summary:
Drug Monograph: New drug monograph
Patient Info Sheet EN: New drug information sheet
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Updated
Jul 2025
Regimen
Published Date: 30 Jun 2025
Cancer Type:
Gynecologic, 
Endometrial
Intent: Adjuvant, Curative, Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Jun 2025
Regimen
Published Date: 30 Jun 2025
Cancer Type:
Gynecologic, 
Endometrial
Intent: Adjuvant, Curative, Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Jun 2025
Drug

Published Date: 24 Jun 2025

Revision Summary:
Drug Monograph: New drug monograph
Patient Info Sheet EN: New patient information sheet
Updated
Jun 2025
Regimen
Published Date: 24 Jun 2025
Cancer Type:
Endocrine, 
Pancreatic Neuroendocrine, 
Genitourinary, 
Renal cell / Kidney
Intent: Curative, Palliative
Revision Summary:

Regimen Monograph: Expanded into full regimen monograph

Updated
Jun 2025
Regimen
Published Date: 20 Jun 2025
Cancer Type:
Breast, 
Central Nervous System, 
Endocrine, 
Adrenal, 
Neuroendocrine, 
Pancreatic Neuroendocrine, 
Parathyroid, 
Thymoma, 
Thyroid, 
Gastrointestinal, 
Anus, 
Colorectal, 
Esophagus, 
Gastric / Stomach, 
Gastrointestinal Stromal Tumours, 
Hepatobiliary / Liver / Bile Duct, 
Mesothelioma (Peritoneal), 
Neuroendocrine (GI), 
Pancreas, 
Rectal, 
Small bowel and appendix, 
Genitourinary, 
Bladder / Urothelial, 
Penile, 
Prostate, 
Renal cell / Kidney, 
Testis, 
Gynecologic, 
Cervix, 
Endometrial, 
Germ Cell, 
Gestational Trophoblastic Disease, 
Ovary, 
Uterine Sarcoma, 
Vagina, 
Vulva, 
Head and Neck, 
Larynx, 
Nasopharynx, 
Oral, 
Paranasal Sinus, 
Pharynx, 
Salivary Gland, 
Squamous Cell, 
Kaposi's Sarcoma, 
Lung, 
Mesothelioma (Pleural), 
Neuroendocrine (Lung), 
Non-Small Cell, 
Small Cell, 
Mesothelioma, 
Ocular / Eye, 
Sarcoma, 
Desmoid Tumour, 
Ewing's, 
Ewing's and Soft Tissue, 
GIST, 
Giant Cell Tumour, 
Kaposi's Sarcoma, 
Osteogenic / Bone, 
Soft Tissue, 
Uterine, 
Wilm's Tumour, 
Skin, 
Basal Cell, 
Melanoma, 
Merkel Cell, 
Squamous Cell, 
Unknown Primary
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

New
Jun 2025
Regimen
Published Date: 20 Jun 2025
Cancer Type:
Lung, 
Non-Small Cell
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Drug regimen, and Cycle frequency sections; Added NDFP form

Updated
Jun 2025
Regimen
Published Date: 20 Jun 2025
Cancer Type:
Hematologic, 
Lymphoma - Hodgkin
Intent: Curative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplementary Public Funding, and Premedication/Supportive Measure sections

Updated
Jun 2025
Drug

Published Date: 20 Jun 2025

Revision Summary:


Drug Monograph: Added NDFP forms

Updated
Jun 2025
Drug

Published Date: 20 Jun 2025

Revision Summary:


Drug Monograph: Added NDFP forms

Updated
Jun 2025
Regimen
Published Date: 18 Jun 2025
Cancer Type:
Hematologic, 
Rare Diseases
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Pregnancy/Lactation section

Updated
Jun 2025

Pages